pharmaceutical investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
pharmaceutical investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
pharmaceutical investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
NevGold Announces Up To 53.7% Antimony, And Fourteen Samples Over 2% Antimony, From Surface Sampling On Pre-Strip Dump
TomaGold Completes Extension Drilling Program at Berrigan Mine and Launches Major Prospecting and Geophysical Survey Campaign Across its Chibougamau Properties
